SHPRH expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.7608137170555E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.05889999785825E-08 |
Normal-vs-Stage2 |
1.90960000001628E-06 |
Normal-vs-Stage3 |
1.0325074129014E-14 |
Normal-vs-Stage4 |
1.63935531816151E-12 |
Stage1-vs-Stage2 |
3.379800E-01 |
Stage1-vs-Stage3 |
1.035340E-04 |
Stage1-vs-Stage4 |
3.10130000003017E-06 |
Stage2-vs-Stage3 |
6.606300E-02 |
Stage2-vs-Stage4 |
1.877650E-02 |
Stage3-vs-Stage4 |
4.183800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.89126492244895E-12 |
Normal-vs-AfricanAmerican |
2.29840000032233E-07 |
Normal-vs-Asian |
1.481590E-01 |
Caucasian-vs-AfricanAmerican |
7.563600E-01 |
Caucasian-vs-Asian |
2.813200E-01 |
AfricanAmerican-vs-Asian |
2.839400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.48450174164827E-14 |
Normal-vs-Female |
5.3130000399193E-09 |
Male-vs-Female |
5.323900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.42659999999395E-05 |
Normal-vs-Age(41-60Yrs) |
8.90569995526391E-09 |
Normal-vs-Age(61-80Yrs) |
1.65611968583335E-12 |
Normal-vs-Age(81-100Yrs) |
6.47030000022752E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.571000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.629400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.615800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.569800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.592100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.207400E-01 |
Normal-vs-Grade 2 |
4.97940000010466E-07 |
Normal-vs-Grade 3 |
1.6251444634463E-12 |
Normal-vs-Grade 4 |
4.44089209850063E-16 |
Grade 1-vs-Grade 2 |
3.540300E-02 |
Grade 1-vs-Grade 3 |
8.37550000000187E-05 |
Grade 1-vs-Grade 4 |
1.50850000046887E-07 |
Grade 2-vs-Grade 3 |
1.409570E-04 |
Grade 2-vs-Grade 4 |
1.281200001646E-08 |
Grade 3-vs-Grade 4 |
6.719700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.84541999999066E-05 |
Normal-vs-ccB subtype |
1.63147273468667E-12 |
ccA subtype-vs-ccB subtype |
4.86559999957059E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.67119684546924E-11 |
Normal-vs-N1 |
1.0400000000077E-06 |
N0-vs-N1 |
4.238300E-02 |
|
|